MariMed Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

NOTE 10 - LOSS ON EXTINGUISHMENT OF DEBT

NOTE 10 - LOSS ON EXTINGUISHMENT OF DEBT	9 Months Ended
Sep. 30, 2014
Debt Disclosure [Abstract]
NOTE 10 - LOSS ON EXTINGUISHMENT OF DEBT	NOTE 10 LOSS ON EXTINGUISHMENT OF DEBT During the nine months ended September 30, 2014, the Company issued 129,688 shares of common stock with a $29,828 fair market value to pay off the accrued expense in amount of $10,750. The $19,078 difference between the fair market value of the common stock and the balance of accrued expense was booked as loss on extinguishment of debt.

NOTE 10 - LOSS ON EXTINGUISHMENT OF DEBT

9 Months Ended

Sep. 30, 2014

NOTE 10 - LOSS ON EXTINGUISHMENT OF DEBT

NOTE 10 LOSS ON EXTINGUISHMENT OF DEBT

During the nine months ended September 30, 2014, the Company issued 129,688 shares of common stock with a $29,828 fair market value to pay off the accrued expense in amount of $10,750. The $19,078 difference between the fair market value of the common stock and the balance of accrued expense was booked as loss on extinguishment of debt.